CEL-SCI CORPORATION Chart calendar CEL-SCI Corporation
149ea56af903de8aa2aaea8f266497.3TRB_1R4o_o6GQ512YGTndkDQZfSWp23CKgHhr3O89s.ml8ErRAo0KIOX28Pk83-1rYwJa6Hatr_O5tJs4yrwayqfTO5OjLgpXcgOg~825404feadb46f00a8f4105349f08e2c
Upcoming events on CEL-SCI Corporation
Past events on CEL-SCI Corporation
| 18/04/2024 | Annual General Meeting |
| 15/02/2024 13:00 | Q1 2024 Earnings Release |
| 22/12/2023 13:00 | Q4 2023 Earnings Release |
| 19/10/2023 | European Society for Medical Oncology Congress |
| 11/08/2023 13:00 | Q3 2023 Earnings Release |
| 07/07/2023 | American Head and Neck Cancer Society International Conference |
| 23/05/2023 15:00 | Annual General Meeting |
| 12/05/2023 | European Society for Radiotherapy and Oncology Congress |
| 12/05/2023 | Q2 2023 Earnings Release |
| 07/03/2023 | Head & Neck Oncology European Congress |
| 15/02/2023 14:00 | Q1 2023 Earnings Release |
| 28/12/2022 14:00 | FY 2022 Earnings Release |
| 09/09/2022 | European Society for Medical Oncology Congress |
| 15/08/2022 14:00 | Q3 2022 Earnings Release |
| 13/06/2022 15:00 | Annual General Meeting |
| 08/06/2022 21:30 | LD Micro Invitational Conference |
| 05/06/2022 | American Society of Clinical Oncology Meeting - Abstract 6032 |
| 02/06/2022 | American Society of Clinical Oncology Meeting |
| 16/05/2022 13:50 | Interim 2022 Earnings Release |
| 14/02/2022 14:00 | Q1 2022 Earnings Release |
Annual results
| Fiscal Period | Settembre | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,46 0,50 -7.45% | 0,56 0,60 -6.89% | 0,00 0,10 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | -32,2 -31,8 -1.36% | -27,5 -26,7 -2.93% | -40,2 |
|
EBIT Million USD | Released Forecast Spread | -20,2 -17,9 -12.82% | -29,0 -24,2 -19.77% | -36,2 -32,8 -10.35% | -36,1 -34,1 -5.91% | -31,5 -31,2 -1.05% | -27,6 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -22,1 -21,0 -5.4% | -30,3 -28,9 -4.76% | -36,4 -34,0 -6.94% | -36,7 -35,7 -2.8% | -32,4 -31,9 -1.46% | -28,4 |
|
Net income Million USD | Released Forecast Spread | -22,1 -21,0 -5.4% | -30,3 -28,9 -4.76% | -36,4 -34,0 -6.94% | -37,6 -35,7 -5.41% | -32,4 -31,9 -1.46% | -28,4 |
|
EPS USD | Released Forecast Spread | -0,71 -0,64 -10.94% | -0,82 -0,77 -6.49% | -0,90 -0,79 -13.92% | -0,87 -0,83 -4.82% | -0,73 -0,71 -2.82% | -0,51 |
| Announcement Date | 16/12/19 | 29/12/20 | 21/12/21 | 27/12/22 | 21/12/23 | - |
Quarterly results
| Fiscal Period | Settembre | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | ||
|
EBITDA Million USD | Released Forecast Spread | -8,57 -3,60 -138.13% | -7,74 -7,00 -10.58% | -7,97 -7,50 -6.2% | -6,66 -7,90 15.67% | ||||||||
|
EBIT Million USD | Released Forecast Spread | -9,55 -7,25 -31.75% | -8,72 -7,05 -23.68% | -8,95 -6,95 -28.75% | -7,65 -8,90 14.04% | -8,18 -7,50 -9.02% | -8,18 -7,65 -6.95% | -7,47 -7,50 0.43% | -6,90 | -7,20 | -7,00 | ||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -9,82 -7,55 -30.11% | -9,63 -7,35 -31.06% | -8,46 -7,25 -16.72% | -7,85 -9,20 14.64% | -8,34 -7,60 -9.77% | -8,37 -7,70 -8.67% | -7,63 -7,70 0.9% | -7,10 | -7,40 | -7,20 | ||
|
Net income Million USD | Released Forecast Spread | -8,78 | -9,82 -7,55 -30.11% | -9,93 -7,35 -35.06% | -9,10 -7,25 -25.47% | -8,03 -9,20 12.77% | -8,34 -7,60 -9.77% | -8,37 -7,70 -8.67% | -7,63 -7,70 0.9% | -6,71 | -7,10 | -7,40 | -7,20 |
|
EPS USD | Released Forecast Spread | -0,20 | -0,23 -0,18 -31.43% | -0,23 -0,17 -35.29% | -0,21 -0,17 -27.27% | -0,18 -0,21 14.29% | -0,19 -0,17 -11.76% | -0,19 -0,16 -18.75% | -0,16 -0,16 0% | -0,14 | -0,14 | -0,13 | -0,11 |
| Announcement Date | 11/02/22 | 13/05/22 | 12/08/22 | 27/12/22 | 14/02/23 | 12/05/23 | 11/08/23 | 21/12/23 | 14/02/24 | - | - | - |
| 06/05/2024 12:00 | AXSOME THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 06/05/2024 | BIOTEST AG: Q1 2024 Earnings Release |
| 06/05/2024 | AVIDITY BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected) |
| 06/05/2024 | APELLIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 07/05/2024 07:00 | BIOGAIA AB: Q1 2024 Earnings Release |
| 07/05/2024 12:30 | INTRA-CELLULAR THERAPIES, INC.: Q1 2024 Earnings Release |
| 07/05/2024 | CATALYST PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 07/05/2024 | ZAI LAB LIMITED: Q1 2024 Earnings Release |
| 08/05/2024 12:55 | VERICEL CORPORATION: Q1 2024 Earnings Release |
| 08/05/2024 | NXERA PHARMA CO., LTD.: Q1 2024 Earnings Release |
Past sector events for CEL-SCI Corporation
| 02/05/2024 21:05 | TWIST BIOSCIENCE CORPORATION: Q2 2024 Earnings Release |
| 02/05/2024 12:50 | ARBUTUS BIOPHARMA CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 12:30 | BRIDGEBIO PHARMA, INC.: Q1 2024 Earnings Release |
| 01/05/2024 | SK BIOSCIENCE CO.,LTD.: Q1 2024 Earnings Release |
| 30/04/2024 12:00 | INCYTE CORPORATION: Q1 2024 Earnings Release |
| 29/04/2024 | SHANDONG SINOBIOWAY BIOMEDICINE CO., LTD.: Q4 2023 Earnings Release |
| 29/04/2024 | SHANDONG SINOBIOWAY BIOMEDICINE CO., LTD.: Q1 2024 Earnings Release |
| 29/04/2024 | BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED: Q4 2023 Earnings Release |
| 29/04/2024 22:53 | SINOVAC BIOTECH LTD.: Q4 2023 Earnings Release |
| 28/04/2024 | SHANGHAI OPM BIOSCIENCES CO., LTD.: Q4 2023 Earnings Release |
